Sun et al. demonstrated that patients with metastatic colorectal cancer had higher serum levels of exosome-derived ADAM17 and that exosomal ADAM17 could facilitate colorectal cancer cell migration by cleaving the E-cadherin junction [45]. The gene discussed is ADAM17; the disease is metastatic colorectal cancer.